Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4

Core Viewpoint - Axsome Therapeutics, Inc. is set to report its financial results for Q2 2025 on August 4, 2025, before U.S. market opening, followed by a conference call for discussion [1] Company Overview - Axsome Therapeutics is a biopharmaceutical company focused on treating central nervous system (CNS) disorders, with a portfolio that includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness related to narcolepsy and obstructive sleep apnea, and migraine [3] - The company aims to address significant gaps in care by developing differentiated products with novel mechanisms of action, impacting over 150 million people in the U.S. [3] Financial Communication - The conference call to discuss financial results will take place at 8:00 a.m. Eastern Time, and a live webcast will be available on the company's website [2] - A replay of the conference call will be accessible for approximately 30 days post-event [2]